Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of Signal Transducer and Activator of Transcription Factor 3 (STAT3)-mediated Astrogliosis on the Pathogenesis of Degenerative Cervical Myelopathy (DCM).
FY 2022-23
Summary
Degenerative cervical myelopathy (DCM), is the most common cause of spinal cord dysfunction amongst adults over the age of 55, involving the chronic and progressive degeneration of the cervical spinal cord. In DCM, spinal structures compress the cervical spinal cord, leading to a variety of painful neurological deficits. Currently, the sole treatment for this disease is surgical decompression (DEC) to release pressure on the spinal cord. Unfortunately, a significant portion of these patients continue to experience neurological deficits post-operatively. With the growing aging population in Canada, the incidence of DCM is expected to increase, making it critical to develop novel treatments.
Previous work in our lab has demonstrated that these complications can be explained by ischemic reperfusion injury (IRI) that occurs once blood flow is re-established upon decompression, resulting in a deleterious inflammatory response. Importantly, astrocytes have been shown to play a critical neuroprotective role in many ischemic settings. However, the role of astrocytes, whether protective or deleterious, in DCM, is currently unknown. Thus, the overall goal of this project is to determine the role of astrocytes in 1) the pathogenesis of DCM itself, and 2) following IRI from surgical decompression.
To examine these questions, we will use a genetically modified mouse model, where a critical pathway for astrogliosis is deleted, and perform behavioural and molecular analysis to determine the effects of the deletion on recovery after DCM and DEC. Ultimately, we hope this work will further our current understanding of the mechanisms underlying the pathogenesis of DCM and uncover potential therapeutic targets to improve patient outcomes, in conjunction with surgical decompression.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486252
Name
Sadat Sarah
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Signal Transducer and Activator of Transcription Factor 3 (STAT3)-mediated Astrogliosis on the Pathogenesis of Degenerative Cervical Myelopathy (DCM).
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Astrogliosis; Degenerative Cervical Myelopathy (Dcm); Glial Response; Immunohistochemistry (Ihc); Inflammation; Neurodegeneration; Neuroregeneration; Signal Transducer And Activator Of Transcription Factor 3; Spinal Cord Injury (Sci)
Abstract
Degenerative cervical myelopathy (DCM), is the most common cause of spinal cord dysfunction amongst adults over the age of 55, involving the chronic and progressive degeneration of the cervical spinal cord. In DCM, spinal structures compress the cervical spinal cord, leading to a variety of painful neurological deficits. Currently, the sole treatment for this disease is surgical decompression (DEC) to release pressure on the spinal cord. Unfortunately, a significant portion of these patients continue to experience neurological deficits post-operatively. With the growing aging population in Canada, the incidence of DCM is expected to increase, making it critical to develop novel treatments.
Previous work in our lab has demonstrated that these complications can be explained by ischemic reperfusion injury (IRI) that occurs once blood flow is re-established upon decompression, resulting in a deleterious inflammatory response. Importantly, astrocytes have been shown to play a critical neuroprotective role in many ischemic settings. However, the role of astrocytes, whether protective or deleterious, in DCM, is currently unknown. Thus, the overall goal of this project is to determine the role of astrocytes in 1) the pathogenesis of DCM itself, and 2) following IRI from surgical decompression.
To examine these questions, we will use a genetically modified mouse model, where a critical pathway for astrogliosis is deleted, and perform behavioural and molecular analysis to determine the effects of the deletion on recovery after DCM and DEC. Ultimately, we hope this work will further our current understanding of the mechanisms underlying the pathogenesis of DCM and uncover potential therapeutic targets to improve patient outcomes, in conjunction with surgical decompression.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sadat, Sarah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~